Search clinical trials for: Meta 18.06 Day and Meta 18.06 Night

Total 6408 results

Biogen

Completed

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Multiple Sclerosis

United States
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)

Pregnancy | Neonates
Alcon Research

Enrolling by invitation

Air Optix® Night and Day® Aqua Therapeutic Wear

Corneal Edema | Bullous Keratopathy | Corneal Dystrophy | Entropion | Corneal Erosion

United States
Alcon Research

Enrolling by invitation

Air Optix® Night and Day® Aqua Continuous Wear

Refractive Errors

United States
University of Maryland, Baltimore

Not yet recruiting

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Acute Pain | Sickle Cell Disease | Vaso-occlusive Pain Episode in Sickle Cell Disease

United States
University of Medicine and Dentistry of New Jersey

Completed

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI (BECOME)

Multiple Sclerosis

United States
Seoul National University Bundang Hospital

Completed

The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

Helicobacter Infection
Maastricht University Medical Center

Completed

Post-exercise Recovery After Dietary Protein Ingestion in Healthy Young Men (Meat-Milk Study) (Meat-Milk)

Skeletal Muscle Hypertrophy

Netherlands
Alcon Research

Enrolling by invitation

Air Optix® Night and Day® Aqua Daily Wear

Refractive Errors | Myopia | Hyperopia

United States
University Hospitals Cleveland Medical Center
Alcon Research

Completed

Daily Wear Corneal Infiltrative Event Study (DWCIE)

Myopia | Hyperopia | Corneal Infiltrative Events

United States
Bayer

Completed

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon

Multiple Sclerosis, Relapsing Remitting

Belgium, Bosnia and Herzegovina, Italy, Austria, Croatia, Czechia, France, Greece, Hungary, Spain, Switzerland
GGZ Buitenamstel
Netherlands Institute for Brain Research, Amsterdam, The Netherlands.

Terminated

Light Therapy for Elderly Depression

Major Depressive Disorder

Netherlands
University of Manitoba
Agriculture and Agri-Food Canada

Completed

Effect of Beta-Glucan on Cholesterol Lowering

Hypercholesterolemia

Canada
Biogen
Elan Pharmaceuticals

Terminated

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis (SURPASS)

Relapsing Remitting Multiple Sclerosis

United States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
University of Rochester
Johns Hopkins University; Massachusetts General Hospital; University of California... and other collaborators

Completed

Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)

Huntington's Disease

United States
Organon and Co

Completed

Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)

In Vitro Fertilization
Aaron Boster
Pfizer; EMD Serono

Completed

Combination Therapy Using Cellcept and Rebif in RRMS

Multiple Sclerosis

United States
Biogen

Completed

Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy (PLENO)

Relapsing Remitting Multiple Sclerosis

Portugal
IMDEA Food

Completed

Human Study of Functional Meat Products

Healthy Volunteers

Spain
Metabolic Technologies Inc.
Iowa State University; South Dakota State University

Completed

Nutritional Intervention for Age-related Muscular Function and Strength Losses

Sarcopenia | Muscle Strength

United States
Air Force Military Medical University, China

Unknown

Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma

Hilar Cholangiocarcinoma

China
Elcelyx Therapeutics, Inc.

Completed

Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects

Healthy Subjects
Allergy Therapeutics

Completed

Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen

Type I Hypersensitivity

Canada
Medical University of South Carolina

Terminated

Chronotherapy Randomized Controlled Trial

Suicidal Ideation | Bipolar Depression | Major Depressive Disorder

United States
Mette M Berger
Texas A&M University

Completed

Can Beta-Hydroxy-beta-Methylbutyrate Supplementation Counteract Muscle Catabolism in Critically Ill Patients? (HMB-ICU-CH)

Critical Illness | Muscle Weakness

Switzerland
Versailles Hospital

Unknown

Short Duration Treatment of Non-severe Community Acquired Pneumonia (PTC)

Community Acquired Pneumonia

France
Innovative Medical

Terminated

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Skin Aging

United States
Allergy Therapeutics

Terminated

Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis

Type I Hypersensitivity

Canada
University of Nottingham

Completed

Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.

Insulin Resistance | Age Problems

United Kingdom
Korea University Guro Hospital

Unknown

Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty (CoM)

Hip Replacement Arthroplasty

Korea, Republic of
Genzyme, a Sanofi Company
Bayer

Completed

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two (CARE-MS II)

Multiple Sclerosis, Relapsing-Remitting

Australia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
Solvay Pharmaceuticals

Completed

Interaction Study SLV337/Simvastatin

Type 2 Diabetes Mellitus

United Kingdom
Biogen
AMS Advanced Medical Services GmbH

Completed

A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis (PERFECT)

Multiple Sclerosis, Relapsing-Remitting

Germany
Allergy Therapeutics

Completed

Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™

Seasonal Allergic Rhinitis

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability

Relapsing Multiple Sclerosis
Guy's and St Thomas' NHS Foundation Trust

Active, not recruiting

A Study to Investigate the Effect of HMB on Skeletal Muscle Wasting in Early Critical Illness (HMB-ICU)

Critical Illness

United Kingdom
University of Roma La Sapienza

Completed

Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation (HMB)

Sarcopenia

Italy
University of California, Los Angeles

Completed

Spices Inhibit the Formation and Absorption of Malondialdehyde From Hamburger Meat

NIDDM
Deutsches Herzzentrum Muenchen

Completed

Safety of Screening Procedures With Hand-held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices

Electromagnetic Interference

Germany, Greece
Azienda Ospedaliero-Universitaria Consorziale Policlinico...
University of Bari

Completed

ProAliFun_6.5_Health Effects of a Functional Pasta Enriched With Barley Beta-glucans on Healthy Subjects (ProAliFun65)

Healthy

Italy
Anderson Orthopaedic Research Institute
DePuy Orthopaedics

Completed

A Five-Year Metal-on-Metal Retrospective Clinical Study

Osteoarthritis

United States
Metabolic Technologies Inc.
Iowa State University

Completed

Effects of HMB Supplementation on Recovery Following ACL Surgery

ACL Injury

United States
Western Galilee Hospital-Nahariya

Unknown

Prevention of Contrast Induced Nephropathy by Erythropoietin

Diabetes | Chronic Kidney Insufficiency

Israel
Biogen

Withdrawn

Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy (Frequency)

Relapsing Multiple Sclerosis
Ankara University

Completed

Comparison of Calcium Channel Blockers and Beta Blockers on Tourniquet-induced Hypertension During Intravenous Regional Anesthesia

Hypertension
RegeneRx Biopharmaceuticals, Inc.

Withdrawn

A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction

ST Elevation Myocardial Infarction | Acute Myocardial Infarction | STEMI
Biocad

Completed

Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis

Multiple Sclerosis

Russian Federation
AbbVie

Recruiting

An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

Dry Eye

United States
Celgene

Completed

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) (SUNBEAM)

Multiple Sclerosis

United States, Spain, Czechia, Russian Federation, Portugal, Serbia, United Kingdom, New Zealand, Belarus, Bulgaria, Poland, Romania, Estonia, Germany, Sweden, Ukraine, Hungary, Croatia, Georgia, Bosnia and Herzegovina, Latvia, Li... and more
Universidad Católica San Antonio de Murcia

Completed

Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists (B-AC1)

Beta Alanine Supplementation

Spain

Search clinical trials for: Meta 18.06 Day and Meta 18.06 Night

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations